Vatican Health Times
SEE OTHER BRANDS

Exploring the health and wellness news of the Vatican

Vatican Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Health Times.

Press releases published on September 4, 2025

Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight

Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight

New York, USA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight The colorectal surgical devices market is predicted to surge owing to the rising incidence of colorectal …

Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform

Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform

NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK) -- Dear Shareholders, I'm writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth …

OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation

OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation

OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation NANTES, France – September 4, 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) reaffirms its strategic commitment to value …

OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur

OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur

OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur NANTES, France – 4 septembre 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) réaffirme, à l’approche de l’ …

Dr. Gregory Facemyer Scholarship Launches Nationwide Essay Contest for Aspiring Medical Doctors

Dr. Gregory Facemyer Scholarship Launches Nationwide Essay Contest for Aspiring Medical Doctors

YOUNGSTOWN, Ohio, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Dr. Gregory Facemyer Scholarship for Medical Students officially opens its application cycle, inviting undergraduate students across the United States to submit original essays that explore the …

Legend Senior Living Welcomes Annalisa Hahn as Senior Vice President of Sales and Marketing

Legend Senior Living Welcomes Annalisa Hahn as Senior Vice President of Sales and Marketing

WICHITA, Kan., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a nationally recognized senior living provider with more than 70 residences across seven states, is pleased to announce the appointment of Annalisa Hahn as Senior Vice President of …

Bay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease Solutions

Bay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease Solutions

PORTOLA VALLEY, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the launch of Bay Area Lyme Ventures (Lyme Ventures), a bold new impact fund that is the first …

AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland

AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland

Latest progress from lead program Ampligen for the treatment of pancreatic cancer highlighted at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025); Presentation now available here Ampligen has …

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen

-New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15-day treatment of Paxlovid ( …

Really Global Launches Global Mental Health Marketplace with 2000+ Search Filters Connecting Clients to Providers in 200+ Countries

Really Global Launches Global Mental Health Marketplace with 2000+ Search Filters Connecting Clients to Providers in 200+ Countries

San Francisco, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Really Global today announced the launch of its comprehensive mental health marketplace that connects clients with therapists, psychologists, nurse practitioners, social workers, coaches, and mentors …

The University of Alabama and GATC Health Unveil Strategic Program to Accelerate Therapeutic Discovery and Development

The University of Alabama and GATC Health Unveil Strategic Program to Accelerate Therapeutic Discovery and Development

IRVINE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, today announced the launch of a strategic program with The University of …

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the execution of a new …

Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204

Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204

Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204 Phase 2/3 Clinical Trials Expected to Commence in First Half of 2026 Following Q4 2025 and Q1 2026 Regulatory Submissions CRO …

Vireo Growth Inc. Comments on Recent Market Activity; Company Unaware of Any Material Change

Vireo Growth Inc. Comments on Recent Market Activity; Company Unaware of Any Material Change

MINNEAPOLIS , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), at the request of the Canadian Investment Regulatory Organization (“CIRO”), today confirmed that Company management is unaware of any …

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York

REYKJAVIK, Iceland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley …

Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option

Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option

VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare solutions, is pleased to announce that it has closed …

Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside

Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside

September 4, 2025 Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move Cambridge, Massachusetts – Philips, a global leader in health technology, today …

Dyadic to Present at Investor Conferences and BPI East

Dyadic to Present at Investor Conferences and BPI East

JUPITER, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, …

Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, Named Pharmacist of the Year by the Florida Society of Health-System Pharmacists

Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, Named Pharmacist of the Year by the Florida Society of Health-System Pharmacists

ORLANDO, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Recognized for his leadership in advancing compounding, championing patient access, and shaping the future of pharmacy, Mark Mikhael, PharmD, CEO of Olympia and Wesley Pharmaceuticals, has been named …

Cinq étudiants touchés par la SLA reçoivent la bourse Kevin Daly 2025 de la Société canadienne de la SLA

Cinq étudiants touchés par la SLA reçoivent la bourse Kevin Daly 2025 de la Société canadienne de la SLA

TORONTO, 04 sept. 2025 (GLOBE NEWSWIRE) -- La Société canadienne de la SLA et le fonds Kevin Daly Bursary Fund sont fiers d’annoncer les récipiendaires de la bourse Kevin Daly 2025 de la Société canadienne de la SLA. Cette année, cinq étudiants de niveau …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions